syndromes

Get An Update on Advances in Migraine and other Headache Syndromes on Webcast

by

OSU Wexner Medical Center logo Get An Update on Advances in Migraine and other Headache Syndromes on Webcast. Just within the past few years, there have been several new agents approved by the FDA for both migraine prevention and acute migraine treatment.

Today on MedNet21, we have invited two of Ohio State University’s Neurology experts to review migraines and other common primary headache syndromes and discuss their treatment options including these new agents. I am so pleased to introduce Drs. Ana Verdecia and Kevin Weber. Ana and Kevin are both fellowship trained in Headache Medicine and Kevin also serves as the division director of Headache medicine at OSU.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Be able to diagnose migraine using ICHD3 criteria
  • Learn about the different treatments currently available for the acute and prophylactic treatment of migraine.
  • Learn about the diagnosis and management of trigeminal autonomic cephalgias
  • Learn about the diagnosis and management of other primary headache disorders.

You’ll also learn about the following:

  • Frequency of Migraines
  • Medication Overuse Headache
  • Prevention
  • Treatment Duration
  • Disability and FMLA

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Myelodysplastic Syndromes on Webcast

by

OSUWexnerbloglogo2014 Learn About Myelodysplastic Syndromes on Webcast. Myelodysplastic syndromes are a group of diseases in which bone marrow cells do not fully mature into normal blood cells, resulting in reduced numbers of blood cells or cytopenias. It is estimated that more than 60,000 Americans have a myelodysplastic syndrome and as our population continues to age, that number will only increase. Joining us today to update us on myelodysplastic syndromes are two specialists in hematology from the Ohio State University. Dr. Katherine Walsh is an Associate Professor of Internal Medicine and Dr. Alice Mims is an Assistant Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the differential diagnosis and work-up of cytopenias, DESCRIBE the differences in prognosis and treatment between lower and higher risk Myelodysplastic Syndrome; RECOGNIZE clinical presentation of MDS and differential diagnosis; and DESCRIBE treatment recommendations for patients with low and high risk MDS.

You’ll also learn about the following:

  • Presenting signs and symptoms of myelodysplastic syndromes
  • Causes of myelodysplastic syndromes
  • Linalidomide
  • Myelodysplastic syndromes and vaccinations
  • When to be concerned about isolated: Leukopenia, Anemia, and Thrombocytopenia.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.